SEKISUI MEDICAL aspires to become the most outstanding global medical company in the world in medical fields, such as in vitro diagnostics.

HOME > Corporate Information > Research & Development
To Previous Page

Research & Development

Tsukuba Research Institute/Tsukuba Diagnostics Development Center

Tsukuba Research Institute

The Tsukuba Research Institute researches new diagnostic products for automated analyzers and POC* testing, using enzymatic analysis, latex turbidimetric immunoassay and polymer technologies in the fields of biochemistry, coagulation, diabetes, infectious diseases and genetic diagnosis.
Using these unique technologies, we have developed many clinically useful products for diagnosis and pre-analytical systems.
*: point of care

Tsukuba Diagnostics Development Center

To introduce the original research findings obtained by the Tsukuba Research Institute into medical laboratories around the world as clinical diagnostics, the Tsukuba Diagnostics Development Center is responsible for the development of highly reliable medical devices based on an international quality management system. These development activities include evaluation studies of clinical effectiveness and validation of the industrialization process on our products.

ADME & TOX. Research Institute

ADME & TOX. Research Institute establishes new drug evaluation systems to meet new drug development regulations related to pharmacokinetic tests, pioneers in the development of the state-of-art technologies, and implements such the state-of art technologies including licensed technologies into contract services.

Iwate Research & Development Center

Based on our synthesis technology of amino-acids and special amino-acids, and on our original technology of peptide synthesis, and in accordance with customer demands, we will develop synthesis methods and industrial processes of pharmaceutical intermediates and active pharmaceutical ingredients (API). At the same time, we will introduce and develop new synthesis technology, production technology and analytical technology.

Amagasaki Research & Development Center

The R&D Center is established to complement the needs of pharmaceutical companies in developing transdermal drug delivery systems (TDDS). A TDDS is a unique dosage form which begins to work once simply affixed to the skin and has several advantages compared to other ordinary forms. We apply our specialized technologies to individual APIs and complete the TDDS formulation for you. Our adjacent GMP plant can provide you with investigational samples for the development and manufacture of commercial products as your contract manufacturer.

To Previous Page